Bone Marrow TransplantationMyelodysplastic SyndromesBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningLeukemiaHematopoietic Stem Cell TransplantationLiver TransplantationTransplantation ChimeraBusulfanTissue DonorsLeukemia, Myeloid, AcuteGraft SurvivalHematopoietic Stem CellsBone Marrow PurgingHistocompatibility TestingBone Marrow DiseasesHistocompatibilityCyclophosphamideAnemia, Refractory, with Excess of BlastsAnemia, RefractoryLeukemia, MyeloidTransplantation, IsogeneicHematopoiesisKidney TransplantationRecurrenceBone Marrow ExaminationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCombined Modality TherapyTreatment OutcomeRemission InductionMice, Inbred C57BLHematologic NeoplasmsRadiation ChimeraImmunosuppressive AgentsAcute DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsBone Marrow NeoplasmsGraft RejectionHepatic Veno-Occlusive DiseaseBone RemodelingStem Cell TransplantationSurvival AnalysisTransplantation ImmunologyLymphoma, Non-HodgkinImmunosuppressionGraft vs Host ReactionPancytopeniaLymphocyte DepletionColony-Forming Units AssayLeukocyte TransfusionHeart TransplantationRetrospective StudiesHematologic DiseasesT-LymphocytesHLA AntigensSevere Combined ImmunodeficiencyChimeraAntineoplastic Combined Chemotherapy ProtocolsCyclosporineCytarabineLung TransplantationSurvival RatePrognosisGranulocyte Colony-Stimulating FactorActuarial AnalysisBone DensityLeukemia, Myelomonocytic, ChronicLymphocyte TransfusionFollow-Up StudiesLeukocyte CountCell DifferentiationNuclear FamilyAntigens, CD34Flow CytometryDisease-Free SurvivalCarmustineOrgan TransplantationGraft vs Tumor EffectMelphalanGraft vs Leukemia EffectCytomegalovirus InfectionsFatal OutcomeEtoposideBone ResorptionSpleenMyeloproliferative DisordersAntilymphocyte SerumMultiple MyelomaLymphomaImmunophenotypingMice, Inbred BALB CGranulocytes